Back to Carlyle Group Inc. Carlyle Group Inc.

VRNAVRNA
7 quarters

Position history for Carlyle Group Inc.Carlyle Group Inc.'s holdings in VERONA PHARMA PLC

No. Carlyle Group exited its VRNA (Verona Pharma) position in Q3 2024. Its Q2 2024 13F listed 2,457,500 shares worth $35.5M. Carlyle Group first reported VRNA in Q1 2023 and held it in 6 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$49.3M

Total Shares Change

-2.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q3
Latest
Exited
0
-100.0%
$00.0%—
0
2024-Q2
Unchanged
2.5M
0.0%
$35.5M3.4%—
0
2024-Q1
Unchanged
2.5M
0.0%
$39.4M2.5%—
0
2023-Q4
Unchanged
2.5M
0.0%
$48.8M2.3%—
0
2023-Q3
Unchanged
2.5M
0.0%
$40M1.7%—
0
2023-Q2
Unchanged
2.5M
0.0%
$51.9M1.8%—
0
2023-Q1
New
2.5M
-
$49.3M1.5%—
68

Other major holders of VRNA: Janus Henderson Group Ltd., Pentwater Capital Management LP, HBK INVESTMENTS L P, BlackRock, Inc., FIL Ltd

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used